The Democratic Republic of Congo has initiated clinical trials for an Ebola vaccine targeting health workers who are on the front lines of the nation’s ongoing outbreak.
Medical authorities aim to determine whether the Ervebo vaccine, which successfully protected populations in prior epidemic events, will offer adequate defense against the specific strain currently circulating in the region.
Health workers in eastern DRC begin receiving the Ervebo vaccine against the Bundibugyo strain as Ebola cases surpass 7,500.
A new CDC report finds fresh produce consumption rises with income, amid food stamp cuts and dietary guideline changes under RFK Jr…
A new study suggests that the mental demands of acquiring a second language may offer significant protective benefits for brain health as…
Hope the local strain hasn’t mutated enough to evade the vaccine. Fingers crossed.
Wait, didn’t Ervebo already get approved for general use? Why the extra trials now?
Is Ervebo available outside this trial? I worry about vaccine equity for rural clinics.
Great news. Protecting healthcare workers is the most critical step in stopping any outbreak.